Madison, CT, United States of America

Boerk Balkan

This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Boerk Balkan. Retrieved from https://idiyas.com/inventor/boerk-balkan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Boerk Balkan: Innovator in Diabetes Treatment

Introduction

Boerk Balkan is a notable inventor based in Madison, CT (US). He has made significant contributions to the field of diabetes treatment through his innovative research and development. His work primarily focuses on methods to reduce hypoglycemic events, particularly those resulting from insulin treatment.

Latest Patents

Boerk Balkan holds a patent for the "Use of DPP-IV inhibitor to reduce hypoglycemic events." This invention relates to a method that aims to minimize severe hypoglycemic events by treating patients with a Dipeptidyl peptidase IV inhibitor (DPP-IV inhibitor) or a pharmaceutically acceptable salt thereof. This patent highlights his commitment to improving patient outcomes in diabetes management. He has 1 patent to his name.

Career Highlights

Throughout his career, Boerk Balkan has been associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in diabetes treatment.

Collaborations

Boerk Balkan has worked alongside notable colleagues such as David G. Holmes and Edwin Bernard Villhauer. These collaborations have further enriched his research and development efforts, leading to advancements in diabetes care.

Conclusion

Boerk Balkan's innovative work in diabetes treatment exemplifies the impact of dedicated inventors in the medical field. His contributions continue to pave the way for improved therapies and patient care in managing diabetes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…